Combined unrelated donor allogeneic hematopoietic stem cell transplantation and unrelated cord blood transfusion for patients with hematological malignancies
Despite the small number of cases, our data show that URD-HSCT in combination with unrelated cord blood transfusion is a safe and effective therapy for patients with intermediate- to high-risk malignant hematological diseases.
Authors
- Yuqiong Yang (ORCID: https://orcid.org/0000-0002-6907-592X)
- Jing Qi (ORCID: https://orcid.org/0000-0001-5020-0842)
- Jun Huang
- Yizhi Jiang (ORCID: https://orcid.org/0000-0002-9386-3678)
- Lanxin Zhang (ORCID: https://orcid.org/0000-0002-3547-9256)
- Zhongling Wei (ORCID: https://orcid.org/0000-0002-2763-0964)
- Nana Wang (ORCID: https://orcid.org/0000-0002-8198-0834)
- Jiawei Yan (ORCID: https://orcid.org/0000-0001-9887-503X)
- Chen Huang (ORCID: https://orcid.org/0000-0002-5707-7063)
- Ran Wang (ORCID: https://orcid.org/0009-0006-1497-2128)
Institutions
- First Affiliated Hospital of Wannan Medical College (CN)
Publication Details
- Journal
- Hematology
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1080/16078454.2025.2496543
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Wannan Medical College